microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Biochemistry and Molecular Biology

• Publication date

  2012-12-24

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 23301201PMCID PMC3533883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD)

  2012cited by this paper
• Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: clinical molecular and genetic studies on Alzheimer's disease.

  2012influential reference
• Evolution and Complexity of Micro RNA in the Human Brain

  2012cited by this paper
• MicroRNAs in Alzheimer's disease.

  2012cited by this paper
• Spreading of Alzheimer's disease inflammatory signaling through soluble micro‐RNA

  2012influential reference
• Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

  2012influential reference
• Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.

  2011influential reference
• Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

  2011cited by this paper
• Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly.

  2011cited by this paper
• Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders

  2011cited by this paper
• Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models

  2011influential reference
• Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.

  2011cited by this paper
• Identifying Earlier Alzheimer’s Disease: Insights from the Preclinical and Prodromal Phases

  2011influential reference
• Identifying and validating biomarkers for Alzheimer's disease

  2011influential reference
• A sensitive non-radioactive northern blot method to detect small RNAs

  2010influential reference
• Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis

  2010cited by this paper
• Cerebrospinal fluid proteins in the diagnosis of Alzheimer's disease.

  2010influential reference
• Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease*

  2010cited by this paper
• Mammalian microRNAs predominantly act to decrease target mRNA levels

  2010cited by this paper
• Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation

  2010influential reference
• Evidence supporting a biological role for aluminum in chromatin compaction and epigenetics.

  2010cited by this paper
• Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

  2010influential reference
• Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

  2009cited by this paper
• Improved northern blot method for enhanced detection of small RNA

  2008influential reference
• An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells*

  2008influential reference
• Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

  2008influential reference
• Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus

  2007cited by this paper
• Natural secretory products of human neural and microvessel endothelial cells

  2007influential reference
• Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease

  2007influential reference
• Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot

  2007influential reference
• Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells.

  2007cited by this paper
• Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

  2006cited by this paper
• Survival signalling in Alzheimer's disease.

  2006cited by this paper
• Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

  2006cited by this paper
• A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

  2005cited by this paper
• Mapping hippocampal and ventricular change in Alzheimer disease

  2004cited by this paper
• Molecular Shuttle Chelation: The Use of Ascorbate, Desferrioxamine and Feralex-G in Combination to Remove Nuclear Bound Aluminum

  2004influential reference
• Cerebrospinal fluid markers for prediction of Alzheimer's disease.

  2003cited by this paper
• Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion.

  2002influential reference
• Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling

  2002cited by this paper
• Gene Expression Analyzed by Microarrays in HSV-1 Latent Mouse Trigeminal Ganglion Following Heat Stress

  2001influential reference
• Strong nuclear factor‐κB‐DNA binding parallels cyclooxygenase‐2 gene transcription in aging and in sporadic alzheimer's disease superior temporal lobe neocortex

  1998cited by this paper
• Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

  1993cited by this paper
• New Evidence for an Active Role of Aluminum in Alzheimer's Disease

  1989cited by this paper

• Effect of Exercise on Regulating miRNA Expression in Brain Health and Diseases

  2025cites this paper
• Diagnostic and therapeutic potential of microRNAs and long noncoding RNAs in the molecular mechanisms of Alzheimer disease

  2025cites this paper
• Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions

  2025cites this paper
• The Role of miRNAs in Parkinson’s Disease: A Systematic Review

  2025cites this paper
• Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability

  2025cites this paper
• MicroRNA biomarkers in cerebrospinal fluid and plasma predicting cognitive decline in Alzheimer's disease

  2025cites this paper
• In silico detection of dysregulated genes and molecular pathways in Alzheimer’s disease as basis for food restoring approach

  2025cites this paper
• RNA-based drugs: current, imminent and possible therapeutic applications.

  2025cites this paper
• MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.

  2024cites this paper
• Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).

  2024cites this paper
• Non-coding RNAs and neuroinflammation: implications for neurological disorders

  2024cites this paper
• Biofluid biomarkers for Alzheimer’s disease: past, present, and future

  2024cites this paper
• A microRNA diagnostic biomarker for amyotrophic lateral sclerosis

  2024cites this paper
• MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review

  2024cites this paper
• Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s Disease

  2024cites this paper
• The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential

  2024influential citation
• The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease

  2024cites this paper
• Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease

  2024cites this paper
• Biological Function Analysis of MicroRNAs and Proteins in the Cerebrospinal Fluid of Patients with Parkinson’s Disease

  2024cites this paper
• Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology

  2024cites this paper
• miRNAs in cerebrospinal fluid associated with Alzheimer's disease: a systematic review and pathway analysis using a data mining and machine learning approach

  2024cites this paper
• Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.

  2023cites this paper
• Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures

  2023cites this paper
• MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease

  2023cites this paper
• The Vascular-Immune Hypothesis of Alzheimer’s Disease

  2023cites this paper
• MicroRNA profiling of cerebrospinal fluid from dogs with steroid responsive meningitis-arteritis and meningoencephalitis of unknown origin

  2023cites this paper
• Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease

  2023cites this paper
• 3D genome-selected microRNAs to improve Alzheimer's disease prediction

  2023cites this paper
• MicroRNAs in tear fl uids predict underlying molecular changes associated with Alzheimer ’ s disease

  2023cites this paper
• Mir125b-2 imprinted in human but not mouse brain regulates hippocampal function and circuit in mice

  2023cites this paper
• Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

  2023cites this paper
• miR‐6076 targets BCL6 in SH‐SY5Y cells to regulate amyloid‐β‐induced neuronal damage

  2023cites this paper
• MiRNA a New Insight in Metabolic and Human Diseases: A Review.

  2023cites this paper
• Sporadic Alzheimer’s Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss

  2022cites this paper
• Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases

  2022cites this paper
• Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders

  2022cites this paper
• The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease

  2022cites this paper
• miRNA-126a-3p Participates in Hippocampal Memory via Alzheimer's Disease-Related Proteins.

  2022cites this paper
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• microRNA-146a as a biomarker for transmissible spongiform encephalopathy.

  2022cites this paper
• Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer’s Disease Compared to Males

  2022cites this paper
• Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice

  2022cites this paper
• Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

  2022cites this paper
• miR-146a Dysregulates Energy Metabolism During Neuroinflammation

  2021cites this paper
• Angiotensin Converting Enzyme 2 (ACE2) Expression in the Visual System

  2021influential citation
• Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.

  2021cites this paper
• Omics Sciences for Systems Biology in Alzheimer's Disease: State-of-the-Art of the Evidence.

  2021cites this paper
• EXPRESSION OF SELECTED miRNAs IN CIRCULATING BLOOD OF EARLY AND LATE-ONSET ALZHEIMER DISEASE PATIENTS

  2021influential citation
• Epigenetics of Alzheimer’s Disease

  2021influential citation
• MiR-155: An Important Regulator of Neuroinflammation

  2021cites this paper
• MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer's disease and amyotrophic lateral sclerosis

  2021cites this paper
• MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration

  2021cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

  2021cites this paper
• A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders

  2021cites this paper
• Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities

  2021cites this paper
• Modulation of noncoding RNAs (ncRNAs) and their potential role as therapeutics

  2021cites this paper
• Angiotensin Converting Enzyme 2 (ACE2) Expression in the Aged Brain and Visual System

  2021influential citation
• Experimental Evidence for Therapeutic Potentials of Propolis

  2021cites this paper
• Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing

  2021cites this paper
• The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning

  2021cites this paper
• Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead

  2021cites this paper
• Neurofilament Light (NF-L) Chain Protein from a Highly Polymerized Structural Component of the Neuronal Cytoskeleton to a Neurodegenerative Disease Biomarker in the Periphery

  2021cites this paper
• The b-Secretase BACE1 in Alzheimer’s Disease

  2020cites this paper
• miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis

  2020influential citation
• MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties

  2020cites this paper
• Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's disease, Depression, Schizophrenia and Ionizing Radiation Exposure.

  2020cites this paper
• Study on the mechanism of curcumin to reduce the inflammatory response of temporal lobe in Alzheimer's disease by regulating miR-146a.

  2020cites this paper
• RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs

  2020cites this paper
• Neuroprotective Effects of Coffee Bioactive Compounds: A Review

  2020cites this paper
• MicroRNA-20b-5p aggravates neuronal apoptosis induced by β-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.

  2020cites this paper
• Propolis: A useful agent on psychiatric and neurological disorders? A focus on CAPE and pinocembrin components

  2020cites this paper
• Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing.

  2020cites this paper
• Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine

  2020cites this paper
• microRNA-Based Biomarkers in Alzheimer’s Disease (AD)

  2020cites this paper
• Performance of Validated MicroRNA Biomarkers for Alzheimer’s Disease in Mild Cognitive Impairment

  2020cites this paper
• Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease

  2020cites this paper
• Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine

  2020cites this paper
• Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease

  2020cites this paper
• MicroRNAs mediate the anti-tumor and protective effects of ginsenosides

  2020cites this paper
• A Circulating MicroRNA Profile in a Laser-Induced Mouse Model of Choroidal Neovascularization

  2020cites this paper
• Genome plasticity and neuropsychiatric disorders

  2020cites this paper
• Utility of Animal Models to Understand Human Alzheimer’s Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals

  2020cites this paper
• Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: present and future applications.

  2020cites this paper
• Biomarkers for Alzheimer’s Disease Early Diagnosis

  2020cites this paper
• Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery.

  2020cites this paper
• Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

  2019cites this paper
• Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology

  2019influential citation
• MicroRNAs change the games in central nervous system pharmacology.

  2019cites this paper
• Alzheimer’s Disease and Intestinal Microbiota Transplantation

  2019cites this paper
• A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease

  2019cites this paper
• miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.

  2019cites this paper
• Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

  2019cites this paper
• MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?

  2019cites this paper
• Atropa belladonna Expresses a microRNA (aba-miRNA-9497) Highly Homologous to Homo sapiens miRNA-378 (hsa-miRNA-378); both miRNAs target the 3′-Untranslated Region (3′-UTR) of the mRNA Encoding the Neurologically Relevant, Zinc-Finger Transcription Factor ZNF-691

  2019cites this paper
• University of Birmingham Small Non-coding RNAs

  2019cites this paper
• Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges

  2019cites this paper
• Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease

  2019cites this paper
• Circulating miRNAs in Successful and Unsuccessful Aging. A mini-review.

  2019cites this paper
• MicroRNA Expression as an Indicator of Tissue Toxicity and a Biomarker in Disease and Drug-Induced Toxicological Evaluation

  2019cites this paper
• Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease

  2019cites this paper